US Edition
Quest Diagnostics acquires Fresenius lab assets for dialysis
Summary by NJBIZ
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Quest Diagnostics acquires Fresenius lab assets for dialysis
Quest Diagnostics completed its acquisition of select assets from Fresenius Medical Care’s laboratory business. As part of the transaction, the Secaucus-based testing provider will now offer dialysis-related clinical testing services to independent clinics that FME subsidiary Spectra Laboratories previously served, according to an Aug. 5 press release. Under a separate agreement, Quest will also begin providing comprehensive dialysis-related lab…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
